These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26880121)

  • 1. Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: a Midwest Pediatric Nephrology Consortium study.
    Seifert ME; Ashoor IF; Chiang ML; Chishti AS; Dietzen DJ; Gipson DS; Janjua HS; Selewski DT; Hruska KA
    Pediatr Transplant; 2016 May; 20(3):378-87. PubMed ID: 26880121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23, NGAL, and Endostatin: the Predictors of Allograft Function in Renal Transplant Recipients.
    Gürlek Demirci B; Sezer S; Uyanık Yıldırım S; Kaynar Erdoğan M; Tutal E; Özdemir Ö; Orazbayev G; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):136-139. PubMed ID: 29528011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are fibroblast growth factor 23 concentrations in renal transplant patients different from non-transplanted chronic kidney disease patients?
    Filler G; Liu D; Sharma AP; Grimmer J
    Pediatr Transplant; 2012 Feb; 16(1):73-7. PubMed ID: 22121948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.
    Bacchetta J; Dubourg L; Harambat J; Ranchin B; Abou-Jaoude P; Arnaud S; Carlier MC; Richard M; Cochat P
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1741-8. PubMed ID: 20157196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients.
    Baia LC; Van den Berg E; Vervloet MG; Heilberg IP; Navis G; Bakker SJ; Geleijnse JM; Kromhout D; Soedamah-Muthu SS; De Borst MH;
    Nutr Metab Cardiovasc Dis; 2014 Dec; 24(12):1310-6. PubMed ID: 25063539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 23 and calcium phosphate homeostasis after pediatric renal transplantation.
    van Husen M; Lehnhardt A; Fischer AK; Brinkert F; Loos S; Oh J; Kemper MJ
    Pediatr Transplant; 2012 Aug; 16(5):443-50. PubMed ID: 22554017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?
    Wesseling-Perry K; Tsai EW; Ettenger RB; Jüppner H; Salusky IB
    Nephrol Dial Transplant; 2011 Nov; 26(11):3779-84. PubMed ID: 21441401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Endocan correlated with stage of chronic kidney disease and deterioration in renal transplant recipients.
    Su YH; Shu KH; Hu CP; Cheng CH; Wu MJ; Yu TM; Chuang YW; Huang ST; Chen CH
    Transplant Proc; 2014; 46(2):323-7. PubMed ID: 24655954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine periostin as a biomarker of renal injury in chronic allograft nephropathy.
    Satirapoj B; Witoon R; Ruangkanchanasetr P; Wantanasiri P; Charoenpitakchai M; Choovichian P
    Transplant Proc; 2014; 46(1):135-40. PubMed ID: 24507039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study.
    Kizilbash S; Claes D; Ashoor I; Chen A; Jandeska S; Matar RB; Misurac J; Sherbotie J; Twombley K; Verghese P
    Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28092129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
    Young A; Hodsman AB; Boudville N; Geddes C; Gill J; Goltzman D; Jassal SV; Klarenbach S; Knoll G; Muirhead N; Prasad GV; Treleaven D; Garg AX;
    Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients.
    Bleskestad IH; Thorsen IS; Jonsson G; Skadberg Ø; Bergrem H; Gøransson LG
    Eur J Endocrinol; 2015 Apr; 172(4):343-50. PubMed ID: 25572388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.
    Oh IH; Lee CH; Kim GH; Kang CM; Park JS
    Artif Organs; 2015 Mar; 39(3):254-9. PubMed ID: 25205383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated Expression of Circulating MicroRNAs in Kidney Transplant Recipients With Interstitial Fibrosis and Tubular Atrophy.
    Zununi Vahed S; Poursadegh Zonouzi A; Ghanbarian H; Ghojazadeh M; Samadi N; Ardalan M
    Iran J Kidney Dis; 2017 Jul; 11(4):309-318. PubMed ID: 28794294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.